Purified influenza virus nucleoprotein protects mice from lethal infection.
about
Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivoStructural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunityProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.New aspects of influenza viruses.Development of universal influenza vaccines based on influenza virus M and NP genes.Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitopeNon-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccinesNew technologies for influenza vaccines.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine designInfluenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in miceGamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administrationInduction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responsesAnimal Models for Influenza Virus Pathogenesis and Transmission.Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virusMouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system.Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoireTargeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytesContribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model.Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity.Bacterially expressed nucleoprotein of infectious hematopoietic necrosis virus augments protective immunity induced by the glycoprotein vaccine in fishA novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.Human influenza vaccines and assessment of immunogenicity.Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes.Some problem areas in the interaction between viruses and the immune system.A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.Vaccine approaches conferring cross-protection against influenza viruses.Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice.Location and architecture of an antibody-binding site of influenza A virus nucleoprotein.
P2860
Q27485211-B5A1EC0A-483F-4A23-B7D1-32ED97D9BAEBQ27486161-9B45CA55-2AF1-40BB-B320-596C3596D715Q30226988-FA7747DD-FEF4-4158-99C0-8451456051B3Q30333613-31EB35D2-6CB0-4A9B-94F2-827FB709C7E6Q30355116-79B76FBE-4FA3-4278-B67F-04FF06BFF1A5Q30372667-1DF17A10-6861-4A59-8467-D6DF0B69C67CQ30395259-520DEDDF-BE56-4BC8-8E6C-2B6C901E4240Q30400347-702B5F4C-72DF-4083-8827-33A5FD1E597AQ30408295-4662E727-C618-4276-9F88-C76202AE7BEDQ30411859-71430CBD-6FA6-4A1E-87C6-A10A617A0DC0Q30416502-9A631FCF-391D-4EAD-A8EF-E7337F26B162Q30425194-9B3DD9A4-4B6D-44E1-A8B4-8C5ECA3B306BQ33805562-0DF93E00-B470-4D5A-9A02-19438876ED09Q33826722-01E992F0-40AA-4160-80D7-A0314CDDE1F5Q33958402-D9F2079E-0A68-4436-B6B1-866A64D4B9AAQ34380312-9390E34F-8EB6-4DBC-B781-86284999A6F0Q34629133-F204D867-5AD9-4156-8F26-20809C3B3195Q34634852-F21E5C49-9CD8-4CD9-8FAF-8EAD367A9F2AQ34714853-99643ED2-A38E-4662-AD3C-71C8B3C33A6CQ34975686-E92D553B-3CEC-42E5-B1D1-04BC253DFF50Q35173733-D28CC79B-D1BE-4D83-A899-373FAFA8E27BQ35831050-FF8891ED-36BB-45DF-A574-8D78C2B65060Q35887546-5FA8E6BF-859C-4DF8-94C8-0A5DFFD24547Q35947917-D04E337F-E57F-44C5-9CA2-93730B884FB3Q36249149-B2678475-B20E-42D8-982B-0B1FA05B8250Q36356008-60FB55A7-0F16-4941-93FE-2007DF463CE2Q36401471-716BDD01-957D-4C2B-9A73-CF872D7E0B66Q36437406-5AF069D7-4727-49E9-B7FF-AB155C7C331EQ36628522-7A3C8658-6F8F-4E02-9D4D-AAA0D66551F0Q36728808-747B0DA6-C0F1-4773-B70F-E1FE5339FE34Q36797460-CC99AD2F-3030-489A-BAE6-697DB93BB149Q36990047-5F22BF50-4625-4E15-9D98-8350E891F027Q37034475-3CF1BD04-47EC-4915-A5A1-A8ED9759D9DCQ37812125-1E64AB32-2215-4269-AA65-CB02ED9E73C9Q39578858-F98E28FB-EA45-4625-AF4E-CDA4DDE98C49Q39679310-DD88A9BF-BA57-4E62-97CE-92A55F1729B7Q40127728-B35F891E-C34C-4148-8C1B-9375A67FB8AEQ41934895-EDD1B122-A71C-4185-9A7A-C9CFE6435420Q42166124-7AEDE182-76F4-4550-8D12-1C41EB50E15CQ42247944-C96975A4-0908-4382-A31C-8802D83FF48A
P2860
Purified influenza virus nucleoprotein protects mice from lethal infection.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Purified influenza virus nucleoprotein protects mice from lethal infection.
@en
type
label
Purified influenza virus nucleoprotein protects mice from lethal infection.
@en
prefLabel
Purified influenza virus nucleoprotein protects mice from lethal infection.
@en
P2093
P1476
Purified influenza virus nucleoprotein protects mice from lethal infection.
@en
P2093
P304
P356
10.1099/0022-1317-68-2-433
P407
P478
68 ( Pt 2)
P577
1987-02-01T00:00:00Z